Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Journal of Gastroenterology and Hepatology
|
December 12, 2013
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats
Han-Chieh Lin, Yi-Tsau Huang, Ying-Ying Yang, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
June 4, 2021
(Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway
Yun-Cheng Hsieh, Kuei-Chuan Lee, Hao-Jan Lei, et al.
Journal of the Chinese Medical Association : JCMA
|
March 20, 2021
Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response
Yun-Cheng Hsieh, Kuei-Chuan Lee, Chien-Wei Su, et al.
Digestive Diseases and Sciences
|
February 1, 2014
Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience
Pei-Chang Lee, Ying-Ying Yang, Ming-Wei Lin, et al.
Journal of Hepatology
|
June 24, 2014
Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites
Ying-Ying Yang, Shie-Liang Hsieh, Pei-Chang Lee, et al.
The American Journal of Pathology
|
June 23, 2018
Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension
Hung-Cheng Tsai, Tzu-Hao Li, Chia-Chang Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 4, 2013
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat
Ying-Ying Yang, Ren-Shyan Liu, Pei-Chang Lee, et al.
Research Square
|
May 20, 2024
Fecal Carriage of Multidrug-Resistant Organisms Increases the Risk of Hepatic Encephalopathy in Cirrhotic Patients: Insights from Gut Microbiota and Metabolite Features
Peishan Wu, Pei-Chang Lee, Tien-En Chang, et al.
Gut Pathogens
|
May 16, 2025
Fecal carriage of multidrug-resistant organisms increases the risk of hepatic encephalopathy in patients with cirrhosis: insights from gut microbiota and metabolite features
Pei-Shan Wu, Pei-Chang Lee, Tien-En Chang, et al.
Plos One
|
November 19, 2016
TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients
Wen-Chien Fan, Chih-Wei Liu, Shuo-Ming Ou, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Journal of Gastroenterology and Hepatology
|
December 12, 2013
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats
Han-Chieh Lin, Yi-Tsau Huang, Ying-Ying Yang, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
June 4, 2021
(Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway
Yun-Cheng Hsieh, Kuei-Chuan Lee, Hao-Jan Lei, et al.
Journal of the Chinese Medical Association : JCMA
|
March 20, 2021
Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response
Yun-Cheng Hsieh, Kuei-Chuan Lee, Chien-Wei Su, et al.
Digestive Diseases and Sciences
|
February 1, 2014
Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience
Pei-Chang Lee, Ying-Ying Yang, Ming-Wei Lin, et al.
Journal of Hepatology
|
June 24, 2014
Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites
Ying-Ying Yang, Shie-Liang Hsieh, Pei-Chang Lee, et al.
The American Journal of Pathology
|
June 23, 2018
Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension
Hung-Cheng Tsai, Tzu-Hao Li, Chia-Chang Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 4, 2013
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat
Ying-Ying Yang, Ren-Shyan Liu, Pei-Chang Lee, et al.
Research Square
|
May 20, 2024
Fecal Carriage of Multidrug-Resistant Organisms Increases the Risk of Hepatic Encephalopathy in Cirrhotic Patients: Insights from Gut Microbiota and Metabolite Features
Peishan Wu, Pei-Chang Lee, Tien-En Chang, et al.
Gut Pathogens
|
May 16, 2025
Fecal carriage of multidrug-resistant organisms increases the risk of hepatic encephalopathy in patients with cirrhosis: insights from gut microbiota and metabolite features
Pei-Shan Wu, Pei-Chang Lee, Tien-En Chang, et al.
Plos One
|
November 19, 2016
TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients
Wen-Chien Fan, Chih-Wei Liu, Shuo-Ming Ou, et al.
Page
of 6